Insider · CIK 0001796224
Dustin S Sjuts
Files at RVNC (Revance Therapeutics, Inc.). First filing Mar 19, 2024, latest Mar 19, 2024.
In brief
Dustin S Sjuts files SEC Form 4 as president at RVNC (Revance Therapeutics, Inc.). Since Mar 19, 2024, Dustin S Sjuts has reported 0 open-market buys worth $0 and 1 open-market sell worth $46k, the latest filed on Mar 19, 2024.
A track record needs three past buys with six months of prices behind them; Dustin S Sjuts has 0, so none is measured yet.
The newest scored trade: sold $46k of RVNC on Mar 18, 2024, filed Mar 19, 2024, scored 41 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Revance Therapeutics, Inc. | $46k 9,211 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 18, 2024 | RVNC Revance Therapeutics, Inc. | 9,500 0.01% of outstanding | $53k | Mar 15, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | RVNC Revance Therapeutics, Inc. | FTax withholding Common Stock | -2,967 | $5.31 | $16k | 176,761 | Mar 19, 2024 |
| Mar 18, 2024 | RVNC Revance Therapeutics, Inc. | SOpen-market sale Common Stock | -9,211 | $5.04 | $46k | 167,550 | Mar 19, 2024 |
| Feb 29, 2024 | RVNC Revance Therapeutics, Inc. | AGrant or award Common Stock | +22,110 | $0.00 | $0 | 179,728 | Mar 4, 2024 |
| Dec 31, 2023 | RVNC Revance Therapeutics, Inc. | AGrant or award Common Stock | +264 | $7.47 | $1,972 | 157,618 | Jan 3, 2024 |
| Dec 15, 2023 | RVNC Revance Therapeutics, Inc. | FTax withholding Common Stock | -4,712 | $8.08 | $38k | 157,354 | Dec 18, 2023 |
Questions about Dustin S Sjuts
Answered from the filings on this page, as of the latest one.
Is Dustin S Sjuts buying or selling?
Not in the last 12 months. Dustin S Sjuts's latest open-market trade on SEC Form 4 was sold $46k of RVNC on Mar 18, 2024.
How did Dustin S Sjuts's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dustin S Sjuts has 0.
Where does Dustin S Sjuts file Form 4?
Dustin S Sjuts has filed Form 4 at RVNC (Revance Therapeutics, Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.